Nutrivert Inc.

SEC filing

Pharmaceuticals · Atlanta, GA

Form D on EDGAR

Amount raised$2.4Msold at filing

Total offering$6M$3.6M still open

Investors in the raise2count reported to the SEC

FiledApr 29, 2026first sale Apr 10, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Bernhard KaltenboeckExecutive Officer, Director

Horace NalleExecutive Officer, Director

Troy MerryDirector

Peter SeloverExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.